Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant, United States

Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant.

• Using data from the National Immunization Survey-Adult COVID Module (NIS-ACM), monthly estimates of receipt and intent for baby’s receipt of nirsevimab reported by females aged 18-49 years with infants under the age of 8 months, females aged 18-49 years who are currently pregnant, and females aged 18-49 years who are currently trying to get pregnant.

• The NIS-ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older.

针对年龄在18至49岁之间，拥有8个月以下婴儿、目前怀孕或正在尝试怀孕的女性，每月对尼瑞西马疫苗接收情况及接种意愿的估计数据。该数据来源于国家免疫调查-成人COVID模块（NIS-ACM）。NIS-ACM是一项针对18岁及以上成年人的持续进行的随机拨号蜂窝电话家庭调查。